February, 2012 | Vol: 10 Issue: 2

In this issue

Learning Objective


Are Clinical Scales Useful for Adult ADHD?

Patients often come into my office to be “tested for ADHD,” and I explain to them that the diagnosis depends on a thorough clinical interview. Nonetheless, rating scales can be useful.

A Boatload of New Data on Stimulants and Cardiac Events


In 2006, an FDA panel recommended all manufacturers of stimulants to add a “black box” warning about an increased risk of “serious cardiovascular events.”

Expert Q&A

Diagnosis and Treatment of ADHD in Adults

To begin with, you have to specify whether you are thinking in terms of DSM-IV criteria or probable DSM-5 criteria. The major difference is that currently you have to establish that ADHD symptoms began before age seven, whereas DSM-5 is more lenient, requiring that they began by age 12.

Research Update

Is Pharmacogenetic Testing Used—and Useful—in Clinical Practice?

For years, we have read articles about the promise of pharmacogenetic testing to help us choose and monitor medication treatment.

How Risky is Pregnancy for Women with a History of Mood Disorders?

We know that the postpartum period is a risky time for women who have a history of depression, especially if they experienced postpartum depression in the past. But several questions about mood and pregnancy are still unanswered.

FDA Publishes Article Critical of Vilazodone Data

It has been over a year now since the approval of vilazodone (Viibryd). As you may recall from our review of the drug in TCPR April 2011, vilazodone is an SSRI with partial agonism at the 5HT1A receptor.